Shenzhen Neptunus Bioengineering Co., Ltd.

Shenzhen Neptunus Bioengineering Co., Ltd.

000078.SZ
Shenzhen Neptunus Bioengineering Co., Ltd.CN flagShenzhen Stock Exchange
1.64
CNY
+0.15
- -
4.32BMarket Cap

Shenzhen Neptunus Bioengineering Co., Ltd. (000078.SZ) Stock Split History

Learn about Shenzhen Neptunus Bioengineering Co., Ltd.'s most recent 5-for-2 basis stock split on May 27, 2016. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Shenzhen Neptunus Bioengineering Co., Ltd.'s most recent stock split

Split Date: 2016-05-27
Split Ratio: 5:2
Price Before Split: $18.45
Price After Split: $7.38

Developer API

Get 000078.SZ split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/000078.SZ

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 2.50 times more shares (a 5:2 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Shenzhen Neptunus Bioengineering Co., Ltd.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2016-05-275:2No$18.45$7.38
2008-06-04543:500No$6.55$6.03
2007-06-1913:10No$12.97$9.98
2006-04-13377:200No$5.04$2.67
2002-06-043:2No$13.06$8.71
1999-04-272:1No$30.26$15.13

About Shenzhen Neptunus Bioengineering Co., Ltd.

Company overview and industry information

Shenzhen Neptunus Bioengineering Co., Ltd. (000078.SZ) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 5-for-2 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Drug Manufacturers - Specialty & Generic
Go to Shenzhen Neptunus Bioengineering Co., Ltd. Summary

Last updated: 7/6/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.